To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.


Already Have an Account?

Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Vol:131 Issue:1 Number:2 ISSN#:2564-2537
ACE Report #14082
Ace Report Cover Osteoarthritis

Efficacy of Harpagophytum procumbens (Teltonal) in Patients with Knee Osteoarthritis

How to Cite

OrthoEvidence. Efficacy of Harpagophytum procumbens (Teltonal) in Patients with Knee Osteoarthritis. ACE Report. 2021;131(1):2. Available from:

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

The Efficacy of Harpagophytum procumbens (Teltonal) in Patients with Knee Osteoarthritis: A Randomized Active-Controlled Clinical Trial

Evid Based Complement Alternat Med. 2021; 2021: 5596892.

Contributing Authors:
HR Farpour N Rajabi B Ebrahimi

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


Thirty-eight patients with knee osteoarthritis were randomized to receive 1 month of Harpagophytum procumbens treatment (n=18) or 10 days of daily meloxicam (n=20). Outcomes of interest included pain on a Visual Analog Scale (VAS), the Oxford Knee Scale (OKS) score, and the Western Ontario and McMaster Universities Arthritis Index (WOMAC) score. Outcomes were assessed at 2, 4 and 8 weeks follow up...

Ace Report Preview Image
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

For Reprints and Permissions, click here

Please Login or Join to leave comments.